ReA, reactive arthritis

Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study
T K Kvien, J S H Gaston, T Bardin, I Butrimiene, B A C Dijkmans, M Leirisalo-Repo, P Solakov, M Altwegg, P Mowinckel, P-A Plan, T Vischer

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1113-1119; DOI: 10.1136/ard.2003.010710
Expression of interferon β in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis
J van Holten, T J M Smeets, P Blankert, P P Tak

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1780-1782; DOI: 10.1136/ard.2005.040477
Relationship between disease activity and infection in patients with spondyloarthropathies
A Martínez, C Pacheco-Tena, J Vázquez-Mellado, R Burgos-Vargas

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1338-1340; DOI: 10.1136/ard.2003.011882
Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study
T Hannu, L Mattila, A Siitonen, M Leirisalo-Repo

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 594-598; DOI: 10.1136/ard.2004.027524
Activation of the STAT1 pathway in rheumatoid arthritis
P V Kasperkovitz, N L Verbeet, T J Smeets, J G I van Rietschoten, M C Kraan, T C T M van der Pouw Kraan, P P Tak, C L Verweij

Annals of the Rheumatic Diseases Mar 2004, 63 (3) 233-239; DOI: 10.1136/ard.2003.013276
Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection
T Hannu, L Mattila, A Siitonen, M Leirisalo-Repo

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 264-266; DOI: 10.1136/ard.61.3.264

Log in using your username and password

Main menu

Log in using your username and password

You are here

ReA, reactive arthritis